Kaiser Permanente’s Mid-Atlantic Neuroscience Institute provides advanced, integrated care for common and complex neurological disorders, including Parkinson’s disease, multiple sclerosis and dementia, supported by a team of award-winning board-certified neurologists and specialists. With 20 neurologists across 37-plus medical centers, the institute completed over 36,000 neurological consultations in 2019, offering services like telehealth assessments, innovative therapies such as deep brain stimulation, and botox treatments for migraines. The institute leads groundbreaking research, participates in National Institutes of Health-sponsored studies, and has contributed to advancements in treatments for movement disorders, multiple sclerosis and stroke recovery. Patients benefit from a coordinated care model that integrates neurologists with primary care and subspecialists, ensuring personalized treatment plans and immediate access to advanced diagnostics. In addition, Kaiser Permanente Los Angeles Medical Center is ranked No. 40 in the nation for neurology and neurosurgery for 2024-25 by U.S. News & World Report.
